Who is Dr. Clay Siegall?
Dr. Clay Siegall’s Ph.D in Genetics is from George Washington University. He also has a Bachelor of Science in Zoology from the University of Maryland. He is the Co-Founder, President, CEO, and Chairman of the Board for Seattle Genetics. Dr. Siegall’s premise for establishing Seattle Genetics, was to stimulate innovative drug research. Siegall’s leadership has skyrocketed his foundation to the top. Seattle Genetics is renown for its developmental research for antibody-drug conjugates for the treating of cancer.
Clay Siegall, Ph.D – Leadership
With Dr. Siegall at the helm, Seattle Genetics has secured several licensure for its ADC research and technology. In addition, SG has several partnerships and collaborations across the board that are currently using SG’s technology to enhance or develop new drugs. Dr. Siegall has raised enough capital to secure more than 675 million dollars to continue SG’s research programs. Some of these collaborators include GlaxoSmtihKline and Pfizer.
Dr. Clay Siegall wears many directorial hats. He is the Director of Ultragenyx Pharmaceutical Inc. He is also the Director of Alder Biopharmaceuticals Inc. He is the Director of Washington Biotechnology and Biomedical Association and many other organizations. Dr. Siegall sits on a multitude of board of directors for many different organizations. His experience has given him the opportunity to author several papers in his field of study. Dr. Clay Siegall holds nine patents to this date. He also wears an editorial hat by serving on the board for three major medical and scientific journals.
Awards and Accolades
Dr. Clay Siegall has several awards and accolades to his name. He has the Pierce Award for his efforts in targeting toxins. He has an entrepreneurial in healthcare award from Ernst & Young Pacific Northwest. He holds the prestigious University of Maryland Alumnus of the Year award for the fields of Computer, Math and Natural Sciences. Dr. Siegall has truly made his mark on the world and in his scientific field of study. He is sure to continue to find new and innovative drugs for fighting cancer and other diseases in the future.